This invention relates to the process of isolating galanthamine and its derivatives in substantially pure form which overcomes the drawbacks of known processes.
Galanthamine, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef]-(2)-benzazepine-6-ol, is a natural alkaloid produced by plants of the family Amaryllidaceae, e.g., genus of Galanthus, Narcissus, Leucojum and Lycoris. Its structure is depicted in
Pharmacologically, galanthamine is a reversible cholinesterase inhibitor like physostigmine but it is substantially less toxic. It also has analgesic and antioxidant properties. This unique combination of properties enables its use for treatment of Alzheimer disease (e.g., L. J. Scott and K. L. Goa, Drugs 2000, 60, 1095-1122) and also alcohol, drugs and nicotine addiction and some other diseases (U.S. Pat. No. 5,643,905).
Although numerous processes for synthesis of galanthamine were described (e.g. Kametani et al., J. Chem. Soc. C, 1971, 6, 1043-1047, or Shimizu et al., Heterocycles, 1977, 8, 277-282, and numerous patents), isolation of galanthamine from plant material is still a useful alternative for large scale manufacture. The common drawback of the known processes for isolation of galanthamine from plant material is the lack of robustness and scalability for large scale isolation. They were usually tailor made for processing of one defined source of plant material. When used for processing of another plant material, they are not capable of producing enough substantially pure galanthamine. The use of toxic and/or environmentally harmful solvents like dichloroethane and other chlorinated hydrocarbons and diethyl ether also discourages these processes for large scale production. Also, some operations employed in these known processes are difficult to scale up, e.g., concentration of the primary extract to dryness and dissolution of the residue in another solvent.
The patent. DE 1,193,061 describes isolation of galanthamine from plants of Amaryllidaceae by extraction of plant material alkalized with aqueous ammonia with dichloroethane or other chlorinated hydrocarbons (dichloromethane, chloroform). The obtained primary extract is further treated with diluted sulfuric acid and the accompanying alkaloids are precipitated with aqueous ammonia. Galanthamine remaining in the solution is extracted with diethylether or dichloromethane and further purified. A substantial improvement of this process is provided in the U.S. Pat. No. 5,877,172. The comminuted plant material (Narcissus pseudonarcissus “Carlton”) is prior to the extraction mixed with powdered sodium carbonate and then extracted with dichloroethane. Further processing of the primary extract is similar as described above but the formation of emulsions is minimized. Nevertheless, the used solvents, dichloroethane and diethyl ether, are not suitable for industrial scale isolation.
The U.S. Pat. No. 5,877,172 also describes extraction of the plant material alkalized prior to the extraction by addition of powdered sodium carbonate with gasoline to obtain primary extract. The primary extract is evaporated to dryness and the dry residue is dissolved in diluted sulfuric acid wherein pH of the solution is adjusted to about 4 and accompanied components of non alkaloid character are extracted by diethyl ether. The obtained refined aqueous solution is alkalized to pH of 9 and the alkaloids are extracted into diethyl ether. The diethyl ether extract is concentrated to dryness followed by the crystallization from 2-propanol to yield galanthamine. Although the use of toxic dichloroethane was eliminated, the process still uses diethyl ether. Moreover the extraction with gasoline is ineffective and requires high volume of solvent. Also, the evaporation of the primary extract to the dry residue is not convenient. The process includes several operations for separation of alkaloids from the ballast, non alkaloid components, but only operation, which assures separation of galanthamine from the other alkaloids, is the crystallization of the alkaloid concentrate from 2-propanol. This fact means that the process is not robust enough to assure the isolation of pure galanthamine from such complex material as described below.
The outline of the state of the art of the extraction of galanthamine from the plant material gives evidence that a robust process for large scale extraction and purification of galanthamine affording high pure product from different plant material is still desirable.
In one aspect, the present invention provides a robust and efficient process for large scale isolation of galanthamine from all known plants producing galanthamine, that are the plants of Amaryllidaceae family, e.g., plants of genera of Galanthus, Narcissus, Leucojum and Lycoris. The used plant material can be dried, e.g. dried leaves or whole aerial parts of the plants, or fresh, e.g. comminuted bulbs and/or aerial parts.
In another aspect, the present invention provides a process for isolation of galanthamine comprising extraction of the plant material with aqueous solution of inorganic or organic acid, thus obtaining a primary extract and adsorption of organic compounds from the primary extract on an adsorbent, washing the adsorbent with water and elution of the organic compounds from the adsorbent with a water miscible organic solvent, thus obtaining the concentrate of alkaloids.
In another aspect, the present invention provides a process for further purification of the concentrate of alkaloids comprising adsorption of alkaloids from the concentrate of alkaloids on a cation exchange polymer resin and elution of alkaloids from the resin with aqueous solution of an inorganic base, obtaining an aqueous alkaloid concentrate.
In another aspect, the present invention provides a process for further purification of the aqueous alkaloid concentrate comprising extraction of alkaloids from the aqueous alkaloid concentrate into an organic solvent not miscible with water and concentrating of the extract obtaining a crude alkaloid concentrate.
In another aspect, the present invention provides a process for further purification of the crude alkaloid concentrate comprising a chromatographic purification of the crude alkaloid concentrate on alumina obtaining a galanthamine fraction using an organic solvent not miscible with water as mobile phase obtaining a purified galanthamine.
In another aspect, the present invention provides a process for further purification of galanthamine comprising crystallization of the purified galanthamine from a suitable solvent, obtaining purified crystalline galanthamine.
In another aspect, the present invention provides a process for further purification of galanthamine comprising re-crystallization of crystalline galanthamine from methyl isobutyl ketone or tert-butyl methyl ether.
In another aspect, the present invention provides a process for further purification of galanthamine comprising liberating galanthamine base from the galanthamine hydrochloride and its crystallization from methyl isobutyl ketone or tert-butyl methyl ether.
In another aspect, the present invention provides a means for removal of narwedine by its reduction with a suitable reducing agent capable of reducing the carbonyl group of narwedine to the secondary alcoholic group.
In another aspect, the present invention provides a process for isolation of high pure galanthamine from all the above mentioned types of plant material. The purity of the isolated galanthamine is more than 80%, preferably more than 90% and even more preferably more than 99%.
In another aspect, the invention provides a process for isolation of substantially pure galanthamine without the use of highly toxic solvents or solvents harmful for environment, e.g., chlorinated hydrocarbons.
The present invention provides a process for isolation of high pure galanthamine from a biomass. The term biomass means dried or fresh parts of plants producing galanthamine, i.e., plants of Amaryllidaceae family, e.g., plants of genera Galanthus, Narcissus, Leucojum, and Lycoris. The process consists of several consecutive steps, which were designed to optimize the efficiency of the isolation process and the capability to remove the undesirable alkaloids which are present in the plant material and must be regarded as the potential impurities of galanthamine. The individual steps were designed in order to avoid the use of toxic solvents or solvents harmful for the environment like chlorinated hydrocarbons and low boiling solvents like diethyl ether, acetone and petroleum ether. The order of individual steps was designed to make overall process efficient.
The first step of the isolation process is extraction of the biomass. It was found by experimentation that diluted aqueous solution of inorganic or organic acids are excellent means for extraction of the plant material. In contrast to known procedures using organic solvents, the aqueous extraction has several advantages: 1) it is not necessary to alkalize the plant material prior to the extraction which eliminates one mechanical operation from the process (mixing of the plant material with powdered sodium carbonate as described in the U.S. Pat. No. 5,877,172); 2) impact on environment is minimized when the extraction solvent is water; 3) it is not necessary to remove the solvent from the extracted material which eliminates another operation from the process (drying of the exhausted biomass); 4) the recovery process of the used solvent is eliminated as well. The selection of the acid used is not critical from the extraction efficiency and selectivity aspects. The selection of the acid is determined by its price, handling and its impact on corrosion of the equipment used if any. The use of phosphoric acid in concentration about 0.1% (w/w) is beneficial. Another advantage of the use of aqueous extraction of the biomass is evident when fresh plant material, e.g., bulbs, are extracted. Since such material contains a lot of water, its extraction with an organic solvent, moreover not miscible with water, will be counterproductive.
The extraction of the biomass can be accomplished by different ways, nevertheless, the use of a battery of percolators is very convenient. The use of battery can minimize the volume of the primary extract. The Example 1 documents that only about 1.5 l of primary extract was obtained from 1 kg of bulbs Nevertheless, when dried biomass is subjected to the extraction on a battery of percolators, the volume of the primary extract is substantially larger due to the low bulk density of the extracted material and large dead volume in the percolator. On the other hand, the dried material need not be comminuted when it is extracted on a battery of percolators as documented in Example 3, where a quantitative extraction was reached using the extraction ratio between the primary extract and dried plant material of 15:1 (v/w).
Next operation of the isolation process is the adsorption of organic compounds present in the primary extract on an adsorbent. It was found out by experimentation that non ionic polymer resin is very suitable adsorbent for this purpose. It was also found out by experimentation that the alkaloids present in the primary extract in form of salts must by transferred to a base form by addition of some inorganic base, e.g., sodium or potassium hydroxide. Then the alkaloids are very efficiently adsorbed on the resin together with some other organic compounds of medium polarity present in the primary extract. Polar organic compounds like saccharides and inorganic compounds are not adsorbed and thus the operation represents an important purification step. The polymeric resin suitable for the adsorption is any poly(styrene-divinylbenzene) co-polymer. The particle size distribution and pore size of the resin are not critical parameters for the efficiency or for the selectivity of the adsorption. The adsorption could be accomplished, e.g., by mixing of the resin with alkalized primary extract, nevertheless, the most convenient is the adsorption on the resin filled in a column. Then the alkalized primary extract can be simply loaded on the column, followed by washing the column with water, and elution of alkaloids and other organic compounds by an organic solvent miscible with water, or a mixture of such solvent and water, conveniently by 60% (v/v) aqueous ethanol, obtaining a concentrate of alkaloids. The concentrate contains all the alkaloids present in the primary extract and some other organic compounds.
The concentrate of alkaloids is further subjected to the adsorption of alkaloids on a cation exchange polymer resin. It was found, that the concentrate of alkaloids obtained by elution from the non ionic polymer resin can be directly loaded on a column filled with the cation exchanger. Although several types of cation exchangers were successfully used, the best results were obtained using strongly acidic cation exchange resin of gel type that is a polysulphonated (styrene-divinylbenzene) co-polymer, crosslinked with not more than 4% of divinylbenzene. Using such type of cation exchange resin, the alkaloids are quantitatively retained while the other organic compounds present in the concentrate are removed. The alkaloids are then desorbed from the column by the elution with aqueous solution of a suitable inorganic base, conveniently, by diluted aqueous ammonia, obtaining thus an aqueous alkaloid concentrate.
The adsorption of alkaloids on a cation-exchanger can be omitted in the case when the content of the organic compounds other than alkaloids in the concentrate of organic compounds is low. Such case is demonstrated in Example 3. Then the concentrate of alkaloids obtained by elution from the non ionic polymer resin can be concentrated to remove the organic solvent and the residual aqueous solution can be alkalized by addition of aqueous ammonia and aqueous alkaloid concentrate obtained by such a way can be subjected to the next purification in a similar way, as the aqueous concentrate obtained by elution from the cation exchanger.
Galanthamine and other lipophilic alkaloids are further extracted from the aqueous solution into an organic solvent. The extract is then concentrated and the obtained crude alkaloid concentrate is further purified by chromatography on alumina. Any solvent not miscible with water with exception of aliphatic hydrocarbons can be used for the extraction of alkaloids from the aqueous concentrate, but the preferred solvents are toluene, methyl isobutyl ketone and/or some esters of acetic acid e.g. propyl acetate, isopropyl acetate, butyl acetate and isobutyl acetate. The advantage of their use is based on fact that identical solvent can be used for chromatographic purification of the crude alkaloid concentrate on alumina so that the mixing of different solvents is minimized and solvent recovery is very simple.
The chromatographic purification of the crude alkaloid concentrate is the first operation capable of separating individual alkaloid. Especially heamanthamine present mainly in the concentrate obtained from plants of Narcissus genus is efficiently separated by this operation as demonstrated in the Example 1 (compare
The combination of chromatography on alumina and crystallization makes it possible to eliminate most of potential impurities with the exception of N-demethylgalanthamine and narwedine as demonstrated in Examples 1 and 3. Narwedine, the biosynthetic precursor of galanthamine, is always present in the plant material used for the isolation of galanthamine. It is practically not eliminated by such a simple chromatography on alumina as described above, and only partially eliminated by crystallization. Another disclosure of the present invention makes it possible to eliminate narwedine from galanthamine. It was found that crystalline galanthamine containing more than about 0.5% narwedine can be purified by reduction of narwedine using a reducing agent capable to reduce the carbonyl group of narwedine providing thus a secondary alcoholic group of galanthamine or epigalanthamine. Such reduction can be accomplished by numerous reducing agents, but exceptionally convenient is the use of sodium borohydride. The galanthamine hydrochloride containing narwedine is dissolved in water and small amount of sodium borohydride is added. Galanthamine isolated from such reaction mixture practically does not contain any narwedine as demonstrated in Example 2.
The process according to the invention is capable of isolating galanthamine of high purity from all above mentioned plant materials. The purity of the product depends on the used plant material, but it was never less than 99%, and in some cases, the purity of isolated galanthamine was even more than 99.5%. Also the yield of the process was very high, usually more than 80% of the calculated amount as demonstrated in Examples 1 and 3.
The present invention is described in the examples below:
The following examples illustrate but do not limit the invention.
Bulbs of narcissus (Narcissus pseudonarcissus “Carlton”) containing 0.12% of galanthamine (determined by HPLC) were comminuted and filled into pilot plant battery of percolators 4×100 l (75 kg of comminuted bulbs was filled into one extractor). Individual filled extractors were joined to the battery and extracted with 0.1% (w/w) aqueous solution of phosphoric acid counter current way. 125 l of primary extract was obtained from one extractor. The HPLC record of the analysis of the primary extract is presented on
The aqueous alkaloid concentrate was extracted with 30 l of methyl isobutyl ketone and the extract was evaporated obtaining about 1 liter of crude alkaloid concentrate. According to HPLC analysis, the concentrate contained 45.8% of galanthamine in dryness—the HPLC record is presented on
30 g of galanthamine hydrochloride prepared above was dissolved in 50 ml of hot water and 12 ml of aqueous ammonia was added to the solution. Crystalline base of galanthamine was separated by filtration and dried. Dry base of galanthamine was recrystallized from 100 ml of methyl isobutyl ketone, obtaining 21.9 g of galanthamine, which purity was determined by HPLC as 99.4%, (the HPLC record is presented on
30 g of galanthamine hydrochloride prepared in Example 1 and containing according to HPLC analysis 1.1% of narwedine was dissolved in 120 ml of water and 1.2 g of sodium borohydride was added in six portions within about 30 minutes under stirring. The solution was stirred for another 30 minutes at laboratory temperature and then 12 ml of 25% (w/w) aqueous ammonia and 200 ml of methyl isobutyl ketone were added to the solution. The organic phase was separated, concentrated to the volume about 100 ml and let to crystallize in refrigerator for 24 hours. The crystalline base of galanthamine was separated by filtration and dried, obtaining 19.3 g of galanthamine, which purity was determined by HPLC as 99.7% and where the content of narwedine was 0.04% (the HPLC record is presented on
40 kg of dried leaves of snowflakes (Leucojum aestivum, L.) containing 0.26% of galanthamine (determined by HPLC) was comminuted and filled into pilot plant battery of percolators 4×100 l (10 kg of comminuted leaves was filled into one extractor). Individual filled extractors were joined to the battery and extracted with 0.1% (w/w) aqueous solution of phosphoric acid by counter-current way. 150 l of primary extract was obtained from one extractor. The HPLC record of the analysis of the primary extract is presented on
The concentrates of alkaloids obtained from all four extractors were combined and evaporated to the volume of 75 l, diluted with water to the final volume of 300 l and pH of the solution was adjusted to about 10 by addition of aqueous ammonia, obtaining aqueous alkaloid concentrate. The concentrate was extracted with 200 l of methyl isobutyl ketone in continuous counter-current extractor. Resulted extract was evaporated to volume of about 1000 ml and loaded on a column filled with 1000 g of basic alumina. The column was eluted with methyl isobutyl ketone and the fractions containing galanthamine (TLC monitoring) were pooled and evaporated to dryness, obtaining 112.5 g of residue (purified galanthamine). The residue was crystallized from 340 ml of tert-butyl methyl ether, obtaining 83.6 g of galanthamine of 99.0% purity as determined by HPLC (the HPLC record is presented on
The process of current invention can be adapted for galanthamine derivatives also. While the invention has been described and illustrated with reference to certain particular embodiments thereof, those skilled in the art will appreciate that various adaptations, changes, modifications, substitutions, deletions, or additions of procedures and protocols may be made without departing from the spirit and scope of the invention. It is intended, therefore, that the invention be defined by the scope of the claims that follow and that such claims be interpreted as broadly as is reasonable.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US06/10247 | 3/17/2006 | WO | 00 | 6/24/2008 |
Number | Date | Country | |
---|---|---|---|
60662585 | Mar 2005 | US |